Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29027892 | 0.86 | GAA (0.36) | GAA | |
| SCHEMBL3082406 | 0.85 | GAA (0.42) | GAACYP4F2CYP4A11 | |
| SCHEMBL26110492 | 0.77 | GAA (0.36) | GAACYP4F2CYP4A11 | |
| SCHEMBL25962173 | 0.77 | GAA (0.36) | GAA | |
| SCHEMBL1476055 | 0.76 | ALDH1A1 (0.37) | CYP4F2CYP4A11 | |
| SCHEMBL25958664 | 0.76 | GAA (0.45) | GAACYP4F2CYP4A11 | |
| SCHEMBL22826020 | 0.75 | GAA (0.33) | GAACYP4F2CYP4A11 | |
| SCHEMBL24373242 | 0.75 | GAA (0.36) | GAACYP4F2CYP4A11 | |
| SCHEMBL29479202 | 0.75 | GAA (0.36) | GAACYP4F2CYP4A11 | |
| SCHEMBL18209774 | 0.74 | CYP4F2 (0.35) | GAACYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250079-A1 | SMALL MOLECULE MODULATORS OF IL-17 | LEO PHARMA A/S (DK) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250079-A1 | SMALL MOLECULE MODULATORS OF IL-17 | IL17A, IL2, IL23R | GAA 920/4885CYP4F2 2305/4885CYP4A11 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.